title: [Use of topical methisoprinol (Viruxan) in female genital condylomatosis].
abstract: Medical therapy of genital condylomatosis seems to be the most rational strategy, since this pathology is characterised by highly frequent recurrences after destructive physical therapy alone. Successful therapy of female genital condylomatosis with methisoprinol (Viruxan), administered as ointment and/or vaginal ovules is reported. The drug proved to be efficient both in curing this viral infection and preventing its recurrences.
authors: C
authors: C
authors: Penna
authors: M G
authors: MG
authors: Fallani
authors: G
authors: G
authors: Cariti
authors: M
authors: M
authors: Menichetti
authors: G L
authors: GL
authors: Bracco
authors: G
authors: G
authors: Bellanti
authors: M
authors: M
authors: Cioffi
authors: M
authors: M
authors: Marchionni
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D003218:Condylomata Acuminata / Q000188:drug therapy*; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged
chemical_list: D007288:Inosine; D007542:Inosine Pranobex
vernacular_title: Utilizzazione del metisoprinolo (Viruxan) per via topica nella condilomatosi genitale femminile.